Tech Company Financing Transactions

Epsilogen Funding Round

Epsilogen, based in London, raised $41.2 million from Novartis Venture Fund, British Patient Capital and Caribou Asset Management.

Transaction Overview

Company Name
Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
The proceeds from the financing will enable Epsilogen to establish clinical proof of concept for lead drug candidate MOv18 IgE in a phase Ib trial in platinum-resistant ovarian cancer, an aggressive cancer with poor treatment alternatives.

Company Information

Company Status
Private & Independent
Mailing Address
London BioScience Innovation Centre 2 Royal College St.
London, NW1 0NH
Email Address
Epsilogen is a global leader in the development of immunoglobulin E (IgE) antibodies to treat cancer. IgE has several key features that make it ideal for the treatment of solid tumours including greater potency, enhanced tumour access and a long tissue half-life.
Epsilogen LinkedIn Company Profile
Social Media
Epsilogen Company Twitter Account
Company News
Epsilogen News
Epsilogen on Facebook
Epsilogen on YouTube

Management Team

Email & Social
Chief Executive Officer
Timothy Wilson
  Timothy Wilson LinkedIn Profile  Timothy Wilson Twitter Account  Timothy Wilson News  Timothy Wilson on Facebook
Chief Financial Officer
Ian Ardill
  Ian Ardill LinkedIn Profile  Ian Ardill Twitter Account  Ian Ardill News  Ian Ardill on Facebook
Chief Scientific Officer
Kevin FitzGerald
  Kevin FitzGerald LinkedIn Profile  Kevin FitzGerald Twitter Account  Kevin FitzGerald News  Kevin FitzGerald on Facebook



Browse more venture capital transactions:

Prev: 3/2/2022: The Host Co. venture capital transaction
Next: 3/2/2022: Tastewise venture capital transaction


Share this article


Where The Data Comes From

We report on tech company VC transactions. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary